Please cite this paper as: Lamont R, Sobel J, Vaisbuch E, Kusanovic J, Mazaki‐Tovi S, Kim
S, Uldbjerg N, Romero R. Parvovirus B19 infection in human pregnancy. BJOG 2011; 118 …

Parvovirus B19 is a significant human pathogen that causes a wide spectrum of clinical
complications ranging from mild, self‐limiting erythema infectiosum in immunocompetent …

60 The International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) is a
scientific 61 organization that encourages sound clinical practice, and teaching and …

Human parvovirus B19 (B19) is common in society. Among adults, more than 50% have
contracted the infection and immunity is believed to last lifelong. Infection occurs in a few …

Since the first evidence of human parvovirus B19 (B19V) infection in late 80s, several
studies have been conducted to clarify the spectrum of clinical diseases in Brazil. B19V …

As most recently demonstrated by the SARS-CoV-2 pandemic, congenital and perinatal
infections are of significant concern to the pregnant population as compared to the general …

This review focuses on the role that human parvovirus B19 nonstructural (NS1) protein as a
transactivator of the proinflammatory cytokine, interleukin‐6 (IL‐6), might play in triggering …

Adverse pregnancy outcome due to human parvovirus B19 (hereafter referred to as
“parvovirus B19”) has been characterized, in numerous reports, as an event that occurs …

Human parvovirus B19 can cause congenital infection with variable morbidity and mortality
in the fetus and neonate. Although much information exists on the B19-specific antibody …

Objective Fetal infection with human parvovirus B19 (hParvo-B19) has been associated
mainly with fetal anemia, although data regarding other fetal hematologic effects are limited …